Drug
GW906 clinical trials
Also written GW906.
Keep track of what changes. Save the GW906 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
4 studies that test it; most in 2025 (2)
| Year | Studies |
|---|---|
| 2025 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses GW906 is read from its arms, and is right about nine times in ten.
Testing it · 4
- An Extension Trial of GW 906 in Participants With Essential HypertensionRecruitingNot applicableShenzhen Salubris Pharmaceuticals Co., Ltd.NCT07879755Written as GW906
- A Study to Evaluate Efficacy and Safety of GW906 Used as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by One or Two Antihypertensive MedicationsNot yet recruitingPhase 2Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT07835984Written as GW906
- The First-in-Human Study of GW906 InjectionCompletedPhase 1Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT07884461Written as GW906 injection
- A Study to Evaluate Efficacy and Safety of GW906 in Patients With Essential HypertensionActive, not recruitingPhase 2Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT07835971Written as GW906